Cargando…
Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
BACKGROUND: Glaucoma is a complex neurodegeneration and a leading cause of blindness worldwide. Current therapeutic strategies, which are all directed towards lowering the intraocular pressure (IOP), do not stop progression of the disease. We have demonstrated that recombinant adeno-associated virus...
Autores principales: | Hines-Beard, Jessica, Bond, Wesley S., Backstrom, Jon R., Rex, Tonia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753658/ https://www.ncbi.nlm.nih.gov/pubmed/26876380 http://dx.doi.org/10.1186/s12974-016-0499-5 |
Ejemplares similares
-
Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
por: Naguib, Sarah, et al.
Publicado: (2023) -
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021) -
The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018) -
Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023) -
Dynamic Ligand Modulation of EPO Receptor Pools, and Dysregulation by Polycythemia-Associated EPOR Alleles
por: Singh, Seema, et al.
Publicado: (2012)